Cargando…

Imaging Glioblastoma With (18)F-Fluciclovine Amino Acid Positron Emission Tomography

INTRODUCTION: Conventional methods of imaging brain tumors fail to assess metabolically active tumor regions, which limits their capabilities for tumor detection, localization, and response assessment. Positron emission tomography (PET) with (18)F-fluciclovine (fluciclovine) provides regional assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scarpelli, Matthew L., Healey, Debbie R., Mehta, Shwetal, Quarles, C. Chad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841434/ https://www.ncbi.nlm.nih.gov/pubmed/35174096 http://dx.doi.org/10.3389/fonc.2022.829050

Ejemplares similares

MRI and amino acid PET detection of whole-brain tumor burden
por: Chen, Peng, et al.
Publicado: (2023)

Simultaneous (18)F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
por: Esmaeili, Morteza, et al.
Publicado: (2018)

Correlation of Tumor Hypoxia Metrics Derived from (18)F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
por: Biscontini, Giuseppina, et al.
Publicado: (2021)

Detection of Recurrent Prostate Cancer With (18)F-Fluciclovine PET/MRI
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2020)

[(18)F]fluciclovine vs. [(18)F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
por: Ferrari, Cristina, et al.
Publicado: (2022)

Multiparametric MRI and [(18)F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma
por: Hassanzadeh, Comron, et al.
Publicado: (2017)

The Role of Preoperative (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma
por: Jo, Sung Jun, et al.
Publicado: (2022)

A practical method for multimodal registration and assessment of whole-brain disease burden using PET, MRI, and optical imaging
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer
por: Glaser, Zachary A., et al.
Publicado: (2018)

Value of Pretreatment (18)F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy
por: Barnes, Chad A., et al.
Publicado: (2020)

Comparison of time curves from dynamic (18)F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
por: Tulipan, Andreas Julius, et al.
Publicado: (2018)

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
por: Wang, Rang, et al.
Publicado: (2021)

Application of Imaging Indicators Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Colorectal Peritoneal Carcinomatosis
por: Sun, Chun-Feng, et al.
Publicado: (2022)

Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
por: Moreau, Aurélie, et al.
Publicado: (2019)

Correlation Study of (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Pathological Subtypes of Invasive Lung Adenocarcinoma and Prognosis
por: Yang, Bin, et al.
Publicado: (2019)

[(18)F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma
por: Valtorta, Silvia, et al.
Publicado: (2021)

Diagnostic Performance and Safety of Positron Emission Tomography Using (18)F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial
por: Wakabayashi, Toshihiko, et al.
Publicado: (2017)

Feasibility of Dose Escalating [(18)F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
por: McDonald, Andrew M., et al.
Publicado: (2019)

Assessment of Amino Acid/Drug Transporters for Renal Transport of [(18)F]Fluciclovine (anti-[(18)F]FACBC) in Vitro
por: Ono, Masahiro, et al.
Publicado: (2016)

Salvage Pelvic Lymph Node Dissection After Fluciclovine Positron Emission Tomography/Computed Tomography Detected Prostate Cancer Recurrence
por: Cancian, Madeline, et al.
Publicado: (2018)

Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)

Value of [(18)F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab
por: Graham, Maya S, et al.
Publicado: (2020)

A Rare Case of Hibernoma Occasionally Identified by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Patient with Lung Cancer
por: Penna, Daniele, et al.
Publicado: (2017)

Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of (18)F-Flurodeoxyglucose Positron Emission Tomography–Computed Tomography in Colorectal Cancer
por: Yin, Yi-xin, et al.
Publicado: (2021)

18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization
por: Zschaeck, Sebastian, et al.
Publicado: (2022)

Exploratory Analysis of Serial (18)F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma
por: Fatania, Kavi, et al.
Publicado: (2022)

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors
por: Michaud, Laure, et al.
Publicado: (2019)

F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012)

Diagnosis of prostatitis by 18-F-fluorodeoxyglucose positron emission tomography
por: Ho, Thien Anh, et al.
Publicado: (2009)

Asymmetric (18)F-fluorination for applications in positron emission tomography
por: Buckingham, Faye, et al.
Publicado: (2016)

(18)F-flutemetamol positron emission tomography in cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2020)

Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)

Neurolymphomatosis detected by (18)F‐fluorodeoxyglucose‐positron emission tomography
por: Hori, Yoshikazu, et al.
Publicado: (2020)

Recent Advances of S–(18)F Radiochemistry for Positron Emission Tomography
por: Deng, Xiaoyun, et al.
Publicado: (2023)

Fluorinated carbohydrates for (18)F-positron emission tomography (PET)
por: Campbell, Emma, et al.
Publicado: (2023)

Prognostic Assessment of Interim F18-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer Treated With Chemoradiation With or Without Surgery
por: Lavertu, Sophie, et al.
Publicado: (2022)

Significance of (18)F-sodium Fluoride Positron Emission Tomography in Characterization of POEMS Osteosclerotic Lesions Better Than (18)F-fluorodeoxyglucose Positron Emission Tomography
por: Marafi, Fahad Abdul Rehman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ngp55k3et209a4428nplqspfpn